Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Change in Accured Expenses (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Change in Accured Expenses for 3 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 338.41% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.0 million, up 403.95%, while the annual FY2025 figure was $2.0 million, 403.95% up from the prior year.
  • Change in Accured Expenses hit $2.4 million in Q4 2025 for Artiva Biotherapeutics, up from $1.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.1 million in Q3 2024 and bottomed at -$3.0 million in Q1 2024.
  • Average Change in Accured Expenses over 3 years is $112800.0, with a median of -$108000.0 recorded in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 964.07% in 2024 and fell as far as 793.71% in 2024.
  • Artiva Biotherapeutics' Change in Accured Expenses stood at $143000.0 in 2023, then plummeted by 793.71% to -$992000.0 in 2024, then soared by 338.41% to $2.4 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $2.4 million, $1.1 million, and -$550000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.